These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 18286570

  • 21. Cytosolic processing of proteasomal cleavage products can enhance the presentation efficiency of MHC-1 epitopes.
    Bulik S, Peters B, Ebeling C, Holzhütter H.
    Genome Inform; 2004; 15(1):24-34. PubMed ID: 15712107
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Virtual models of the HLA class I antigen processing pathway.
    Petrovsky N, Brusic V.
    Methods; 2004 Dec; 34(4):429-35. PubMed ID: 15542368
    [Abstract] [Full Text] [Related]

  • 24. Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.
    Mo XY, Cascio P, Lemerise K, Goldberg AL, Rock K.
    J Immunol; 1999 Dec 01; 163(11):5851-9. PubMed ID: 10570269
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases.
    Lévy F, Burri L, Morel S, Peitrequin AL, Lévy N, Bachi A, Hellman U, Van den Eynde BJ, Servis C.
    J Immunol; 2002 Oct 15; 169(8):4161-71. PubMed ID: 12370345
    [Abstract] [Full Text] [Related]

  • 27. Beyond the proteasome: trimming, degradation and generation of MHC class I ligands by auxiliary proteases.
    Saveanu L, Fruci D, van Endert P.
    Mol Immunol; 2002 Oct 15; 39(3-4):203-15. PubMed ID: 12200051
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. IRAP identifies an endosomal compartment required for MHC class I cross-presentation.
    Saveanu L, Carroll O, Weimershaus M, Guermonprez P, Firat E, Lindo V, Greer F, Davoust J, Kratzer R, Keller SR, Niedermann G, van Endert P.
    Science; 2009 Jul 10; 325(5937):213-7. PubMed ID: 19498108
    [Abstract] [Full Text] [Related]

  • 32. Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.
    Kawahara M, York IA, Hearn A, Farfan D, Rock KL.
    J Immunol; 2009 Nov 15; 183(10):6069-77. PubMed ID: 19841172
    [Abstract] [Full Text] [Related]

  • 33. Two new proteases in the MHC class I processing pathway.
    Stoltze L, Schirle M, Schwarz G, Schröter C, Thompson MW, Hersh LB, Kalbacher H, Stevanovic S, Rammensee HG, Schild H.
    Nat Immunol; 2000 Nov 15; 1(5):413-8. PubMed ID: 11062501
    [Abstract] [Full Text] [Related]

  • 34. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
    De Winter H, Breslin H, Miskowski T, Kavash R, Somers M.
    J Mol Graph Model; 2005 Apr 15; 23(5):409-18. PubMed ID: 15781183
    [Abstract] [Full Text] [Related]

  • 35. Running the gauntlet: from peptide generation to antigen presentation by MHC class I.
    Saunders PM, van Endert P.
    Tissue Antigens; 2011 Sep 15; 78(3):161-70. PubMed ID: 21736566
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.
    Schnurr M, Orban M, Robson NC, Shin A, Braley H, Airey D, Cebon J, Maraskovsky E, Endres S.
    J Immunol; 2009 Feb 01; 182(3):1253-9. PubMed ID: 19155470
    [Abstract] [Full Text] [Related]

  • 38. Proteolytic enzymes involved in MHC class I antigen processing: A guerrilla army that partners with the proteasome.
    Lázaro S, Gamarra D, Del Val M.
    Mol Immunol; 2015 Dec 01; 68(2 Pt A):72-6. PubMed ID: 26006050
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.